Organized by the Clinical Research Institute HUCH and the Helsinki University Hospital Comprehensive Cancer Center/Dept. of Hematology.
Date: Thursday February 14, 2019
Location: Biomedicum Helsinki, lecture hall 1, Haartmaninkatu 8
PROGRAM
| 08:30 | Coffee | |
| 09:00 | Welcome and introduction | Kimmo Porkka Professor, Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology |
| Session I: Updates in hematology (chair: K. Porkka) | ||
| 09:00 | Genome-driven therapy of ALL | Charles Mullighan Professor, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN |
| 09:40 |
Clinical implications of clonal hematopoiesis |
Lambert Busque |
| 10:20 | Coffee, exhibitions | |
| 10:40 | Targeted therapy of AML |
Jorge Cortes |
| 11:20 |
Clinical trials of hematology: are we testing trivialities? |
Vinay Prasad
Assistant Professor of Medicine, Division of Hematology Oncology in the Knight Cancer Institute, OHSU, Portland, OR |
| 12:00 | Lunch | |
|
|
||
|
Session II: Updates in stem cell transplantation |
||
| 13:00 |
Welcome |
Riitta Niittyvuopio |
| 13:00 | DLI and pharmacologic interventions post allo-HSCT | Jürgen Kuball Professor, Department of Hematology, Utrecht Cancer Center |
| 13:50 | Terveisiä Veripalvelusta |
Tiina Linjama |
| 14:20 | Allogeenisen kantasolusiirtopotilaan gynekologinen hoito ja seuranta | Elina Holopainen LT, Naistentautien ja synnytysten erikoislääkäri, HUS |
Eeva Lind-Ekholm (eeva.lind-ekholm@hus.fi, 09-471 74581) 01.02.2019 mennessä. Mainitsethan samalla mahdollisesta erityisruokavaliosta.
Welcome! Tervetuloa!